Patent · US Active

Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases

US11877995B2 · kind B2 · utility

0Cited by

2References

34Claims

0Family size

Assignee

IMMUNIC AG · DE

Inventors

Manfred GRÖPPEL · Erlangen, DE
Daniel VITT · Germering, DE
Hella KOHLHOF · Munich, DE
Andreas Muhler · Oderberg, DE

Key dates

Filing date	Nov 22, 2022
Grant date	Jan 23, 2024
Priority date	—
Expiry date	Nov 22, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention refers to a 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of formula (I) inhibits dihydroorotate dehydrogenase (DHODH), and is known for the treatment and prevention of diseases, in particular their use in diseases where there is an advantage in inhibiting dihydroorotate dehydrogenase (DHODH).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.